Category

General
At Teamit we are proud to announce our involvement in the IHI RealiseD project, an initiative that promises to revolutionise the landscape of clinical trials for ultra-rare diseases. With a €17 million budget, RealiseD unites nearly 40 organisations, including renowned experts and industry professionals from across Europe, all working together to develop innovative solutions for...
Read More
Teamit is pleased to announce the successful renewal of our ISO 9001 certification, reinforcing our commitment to maintaining the highest quality standards and operational excellence. This achievement follows a comprehensive audit of our Quality Management System (QMS), confirming that we meet ISO 9001 standards and are fully equipped to provide consistent, reliable, and quality-driven service...
Read More
Teamit Institute is proud to announce their presence in the new HMA-EMA catalogues. The Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) have launched an innovative tool for stakeholders in European healthcare and pharmacovigilance: the HMA-EMA Catalogues of real-world data sources and studies. These catalogues, launched in February 2024, are comprehensive databases...
Read More
Teamit Institute has formed a strategic partnership with Utrecht University to streamline the European Pharmacoepidemiology & Pharmacovigilance (EU PE&PV) Network management and enhance coordination, particularly for upcoming EMA tenders. This collaboration is set to boost efficiency and foster stronger cooperation in pharmaceutical research across Europe.  The EU PE&PV Research Network is committed to advancing the...
Read More
At Teamit, we are proud to announce that we are part of UMBRELLA, a groundbreaking initiative aimed at transforming stroke care across Europe. Spearheaded by the Vall d’Hebron Research Institute (VHIR) and Siemens Healthineers, UMBRELLA brings together over 20 public and private partners, including Teamit, to revolutionise stroke diagnosis, prevention, and treatment. More than 1...
Read More
Born from discussions and experience in post-marketing real-world evidence studies, Teamit Institute has authored a new White Paper on “Unlocking Real-World Evidence in post-marketing surveillance: The Critical Role of Scientific Management.”  “Our expertise in pharmacovigilance studies has demonstrated that Scientific Managers play a pivotal role in orchestrating collaborative research. Combining a strong scientific background with...
Read More
We are excited to announce the launch of the European Rare Diseases Research Alliance (ERDERA), a groundbreaking initiative set to redefine the landscape of rare disease research and improve the lives of the over 30 million patients across Europe and beyond. With its kick off at the beginning of September, ERDERA represents a monumental step...
Read More
In a groundbreaking collaboration, Teamit, alongside EATRIS, Lygature and ITTM, has authored an interactive Playbook that is set to enhance data sharing in pre-competitive research projects. This new resource has been commissioned by the Innovative Health Initiative (IHI) and EFPIA to unlock the full potential of data sharing and accelerate the development of solutions through...
Read More
The International Society for Pharmacoepidemiology (ISPE) will hold their 40th Annual Meeting in Berlin, August 2024. The ISPE meeting, formerly known as the International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) is an important milestone in the pharmacoepidemiology calendar where academics, industry professionals and experts from across the world gather to share groundbreaking results,...
Read More
The PROMISE (Preparing for RSV Immunisation and Surveillance in Europe) project recently came to a close, delivering tangible results and changing the landscape of RSV prevention and treatment forever. We look back at the journey of this successful public-private partnership in which we had the privilege to participate with our expertise in project management, consortium...
Read More
1 2 3 7